gadolinium has been researched along with Neuroendocrine Tumors in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (50.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheung, HM; Coburn, N; Karanicolas, PJ; Law, C; Milot, L; Shoichet, M | 1 |
Abou, DS; Beattie, BJ; Carlin, SD; Lewis, JS; Pinkse, MW; Ramos, NN; Thorek, DL; Wolterbeek, HT | 1 |
Gueye, C; Laissy, JP; Scherrer, A; Somveille, E; Soyer, P | 1 |
Laissy, JP; Menu, Y; Sibert, A; Soyer, P; Tidjani, K | 1 |
Collins, DJ; Doyle, VL; Leach, MO; Payne, GS; Verrill, MW | 1 |
Bresciani, M; Camera, L; Mainenti, PP; Percopo, V; Salvatore, M; Soscia, E | 1 |
2 review(s) available for gadolinium and Neuroendocrine Tumors
Article | Year |
---|---|
Appearance of Focal Liver Lesions Using Contrast-Enhanced Magnetic Resonance Imaging Using Gadofosveset Trisodium, an Intravascular (Blood-Pool) Contrast Agent: A Pictorial Essay.
Topics: Adenocarcinoma; Adenoma; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Breast Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Cholangiocarcinoma; Colorectal Neoplasms; Contrast Media; Gadolinium; Hemangioma; Humans; Hyperplasia; Kidney Neoplasms; Liver Neoplasms; Magnetic Resonance Imaging; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms | 2016 |
[Morphological imaging of gastroenteropancreatic neuroendocrine tumours].
Topics: Adenoma, Islet Cell; Carcinoid Tumor; Contrast Media; Diagnostic Imaging; Gadolinium; Gastrointestinal Neoplasms; Humans; Magnetic Resonance Imaging; Neoplasm Metastasis; Neoplasm Staging; Neuroendocrine Tumors; Pancreatic Neoplasms; Sensitivity and Specificity; Tomography, X-Ray Computed | 2001 |
4 other study(ies) available for gadolinium and Neuroendocrine Tumors
Article | Year |
---|---|
(89)Zr-labeled paramagnetic octreotide-liposomes for PET-MR imaging of cancer.
Topics: Animals; Cell Line, Tumor; Contrast Media; Gadolinium; Humans; Isotopes; Liposomes; Magnetic Resonance Imaging; Mice; Neuroendocrine Tumors; Octreotide; Positron-Emission Tomography; Receptors, Somatostatin; Zirconium | 2013 |
MR diagnosis of hepatic metastases from neuroendocrine tumors versus hemangiomas: relative merits of dynamic gadolinium chelate-enhanced gradient-recalled echo and unenhanced spin-echo images.
Topics: Abdominal Neoplasms; Adult; Aged; Aged, 80 and over; Chelating Agents; Contrast Media; Diagnosis, Differential; Female; Gadolinium; Hemangioma, Cavernous; Heterocyclic Compounds; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neuroendocrine Tumors; Observer Variation; Organometallic Compounds; Prospective Studies; Sensitivity and Specificity; Statistics, Nonparametric | 1995 |
Dynamic Gd-DOTA-enhanced MR imaging of hepatic metastases from pancreatic neuroendocrine tumors.
Topics: Adult; Aged; Carcinoid Tumor; Chelating Agents; Contrast Media; Female; Gadolinium; Gastrinoma; Heterocyclic Compounds; Humans; Image Enhancement; Insulinoma; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms; Prospective Studies; Retrospective Studies; Vipoma | 1994 |
Quantification of phosphorus metabolites in human calf muscle and soft-tissue tumours from localized MR spectra acquired using surface coils.
Topics: Adenosine Triphosphate; Gadolinium; Gadolinium DTPA; Humans; Leg; Magnetic Resonance Spectroscopy; Muscle Neoplasms; Muscle, Skeletal; Neuroendocrine Tumors; Organometallic Compounds; Pentetic Acid; Phosphates; Phosphocreatine; Phosphorus; Reproducibility of Results; Sensitivity and Specificity; Soft Tissue Neoplasms | 1997 |